Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Interest Coverage Ratio (2021 - 2025)

Historic Interest Coverage Ratio for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to 0.78.

  • Verrica Pharmaceuticals' Interest Coverage Ratio rose 10891.67% to 0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.87, marking a year-over-year increase of 7745.19%. This contributed to the annual value of 7.0 for FY2024, which is 5780.24% up from last year.
  • As of Q3 2025, Verrica Pharmaceuticals' Interest Coverage Ratio stood at 0.78, which was up 10891.67% from 0.71 recorded in Q2 2025.
  • In the past 5 years, Verrica Pharmaceuticals' Interest Coverage Ratio registered a high of 17.88 during Q3 2022, and its lowest value of 14.43 during Q3 2023.
  • For the 5-year period, Verrica Pharmaceuticals' Interest Coverage Ratio averaged around 5.04, with its median value being 7.28 (2022).
  • Over the last 5 years, Verrica Pharmaceuticals' Interest Coverage Ratio had its largest YoY gain of 26588.36% in 2022, and its largest YoY loss of 1183364.14% in 2022.
  • Quarter analysis of 5 years shows Verrica Pharmaceuticals' Interest Coverage Ratio stood at 7.72 in 2021, then soared by 331.53% to 17.88 in 2022, then crashed by 156.15% to 10.04 in 2023, then skyrocketed by 51.61% to 4.86 in 2024, then surged by 116.0% to 0.78 in 2025.
  • Its Interest Coverage Ratio was 0.78 in Q3 2025, compared to 0.71 in Q2 2025 and 3.69 in Q1 2025.